Meet IAG’s Oncology Expert Team at ASCO, Chicago

Meet IAG’s Oncology Expert Team at ASCO, Chicago

Meet IAG’s Oncology Expert Team at ASCO, Chicago 2024

IAG’s team is attending the American Society of Clinical Oncology, ASCO, meeting in Chicago, on June 1-4, 2024.

IAG’s team will be meeting with key biotech companies and addressing the challenges biotech companies face in oncology and neuro oncology trials to explore IAG’s novel strategies to include advanced imaging biomarkers.

IAG partners with biotechnology and pharmaceutical companies and apply AI and Precision Medicine to accelerate drug approval.

IAG takes a holistic approach to biotech’s clinical development and brings together:

  • An efficient purpose-built cloud-based system with embedded quality controls for trial data management (DYNAMIKA)
  • Patented methodologies for quantitative assessment of treatment efficacy and safety
  • Expertise in detecting treatment effects including pseudo-progression and pseudo-response
  • Expertise to ensure regulatory compliance, targeted drug development and scientific credibility of your data
  • Ensures that its bio-pharmaceutical clients gain the most benefits of early objective decision making on their treatment efficacy from utilizing advanced imaging techniques in their trials

Discover our risk assessment and management strategies to overcome the challenges in your oncology trial by contacting IAG at

About ASCO

Founded in 1964, the American Society of Clinical Oncology is the world’s leading professional organization for physicians and oncology professionals caring for people with cancer. The 2018 Annual Meeting brings together more than 32,000 oncology professionals from around the world to discuss state-of-the-art treatment modalities, new therapies, and ongoing controversies in the field. This year’s theme, Delivering Discoveries: Expanding the Reach of Precision Medicine, focuses on making precision medicine a reality by driving progress and expanding its reach so every patient has the chance to benefit. For more information on the conference click here.

About Image Analysis Group (IAG)

Leading imaging Clinical Research Organization that combines medical and operational expertise with cutting-edge proprietary A.I. capabilities to power drug development, and to deliver the potential for companion diagnostic tool. IAG has been serving biotech and pharma clients globally since 2007, reliably supporting all aspects of phase I to III imaging trials across multiple indications. With a pioneering proven innovation strategy, we enhance the value and market potential of novel therapeutic assets, as demonstrated through successful pharmaceutical partnerships.

Learn more:

Reach out:

Follow the Company: Linkedin